Aquestive therapeutics names sherry korczynski as chief commercial officer

Warren, n.j., july 22, 2025 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (“aquestive” or the “company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the promotion of sherry korczynski, from senior vice president of sales and marketing, to chief commercial officer effective july 22, 2025.
AQST Ratings Summary
AQST Quant Ranking